rs8018014

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_020937.4(FANCM):​c.6141T>C​(p.Asp2047Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0167 in 1,606,780 control chromosomes in the GnomAD database, including 396 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 133 hom., cov: 32)
Exomes 𝑓: 0.015 ( 263 hom. )

Consequence

FANCM
NM_020937.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.614

Publications

11 publications found
Variant links:
Genes affected
FANCM (HGNC:23168): (FA complementation group M) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group M. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
FANCM Gene-Disease associations (from GenCC):
  • Fanconi anemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet
  • spermatogenic failure 28
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.006).
BP6
Variant 14-45200002-T-C is Benign according to our data. Variant chr14-45200002-T-C is described in ClinVar as Benign. ClinVar VariationId is 261392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.614 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0695 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCMNM_020937.4 linkc.6141T>C p.Asp2047Asp synonymous_variant Exon 23 of 23 ENST00000267430.10 NP_065988.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCMENST00000267430.10 linkc.6141T>C p.Asp2047Asp synonymous_variant Exon 23 of 23 1 NM_020937.4 ENSP00000267430.5

Frequencies

GnomAD3 genomes
AF:
0.0284
AC:
4323
AN:
152180
Hom.:
132
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0715
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0190
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0142
Gnomad OTH
AF:
0.0277
GnomAD2 exomes
AF:
0.0139
AC:
3497
AN:
251028
AF XY:
0.0127
show subpopulations
Gnomad AFR exome
AF:
0.0692
Gnomad AMR exome
AF:
0.0135
Gnomad ASJ exome
AF:
0.00377
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000647
Gnomad NFE exome
AF:
0.0146
Gnomad OTH exome
AF:
0.0144
GnomAD4 exome
AF:
0.0155
AC:
22513
AN:
1454482
Hom.:
263
Cov.:
28
AF XY:
0.0149
AC XY:
10818
AN XY:
724026
show subpopulations
African (AFR)
AF:
0.0721
AC:
2396
AN:
33220
American (AMR)
AF:
0.0145
AC:
649
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.00364
AC:
95
AN:
26074
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39486
South Asian (SAS)
AF:
0.00418
AC:
360
AN:
86028
European-Finnish (FIN)
AF:
0.00124
AC:
66
AN:
53256
Middle Eastern (MID)
AF:
0.0135
AC:
67
AN:
4950
European-Non Finnish (NFE)
AF:
0.0161
AC:
17855
AN:
1106736
Other (OTH)
AF:
0.0171
AC:
1025
AN:
60050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
932
1865
2797
3730
4662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
734
1468
2202
2936
3670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0285
AC:
4335
AN:
152298
Hom.:
133
Cov.:
32
AF XY:
0.0264
AC XY:
1963
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0716
AC:
2976
AN:
41556
American (AMR)
AF:
0.0190
AC:
291
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00352
AC:
17
AN:
4828
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10614
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0142
AC:
966
AN:
68012
Other (OTH)
AF:
0.0274
AC:
58
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
213
426
640
853
1066
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0197
Hom.:
92
Bravo
AF:
0.0308
Asia WGS
AF:
0.00839
AC:
29
AN:
3472
EpiCase
AF:
0.0133
EpiControl
AF:
0.0142

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 26, 2021
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 29, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Premature ovarian failure 15 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.79
DANN
Benign
0.54
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8018014; hg19: chr14-45669205; COSMIC: COSV57499820; API